IGC Pharma Aligns Fiscal Year with Calendar Year to Enhance U.S. Investor Transparency and Comparability

Core Viewpoint - IGC Pharma has announced a change in its fiscal year end from March 31 to December 31, effective December 31, 2025, to enhance engagement with U.S. investors [1] Company Summary - IGC Pharma is a clinical-stage pharmaceutical company focused on developing innovative treatments for Alzheimer's disease using Artificial Intelligence [1] - The decision to change the fiscal year end is described as a straightforward but important step by the CEO, Ram Mukunda [1]